Arcutis Biotherapeutics (ARQT) Debt/EBITDA US GAAP (year values)

2020 2021 2021 2022 2023   LTM ? CAGR 5 years ?
Debt/EBITDA 2.05 1.50 1.50 0.70 0.28   0.81  
Changes by years, y/y, % -13% -27% 0% -53% -60%     -35.9%

Arcutis Biotherapeutics. Debt/EBITDA

Arcutis Biotherapeutics. Debt/EBITDA, changes, %

Arcutis Biotherapeutics (ARQT) Debt/EBITDA US GAAP (quarter values)

2023Q4 2024Q1 2024Q1 2024Q2 2024Q3   LTM ?
Debt/EBITDA 0.29 1.04 1.12 0.88 0.68   0.81
Changes by years, y/y, % -59% +147% +166% +317% +624%    
Changes by quarters, q/q, % +209% +261% +8% -21% -23%    

Arcutis Biotherapeutics. Debt/EBITDA

Arcutis Biotherapeutics. Debt/EBITDA, changes, y/y, %

Arcutis Biotherapeutics. Debt/EBITDA, changes, q/q, %